Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site

Click on country-registry for comparison

Flag	Country Registry	Registration period	No. of cases included	Complete FU		Incomplete FU: loss to FU						% with Complete FU at 5 years	Median FU (in months)
				Alive/dead	At end of FU	No.	%	% lost to FU: years from diagnosis
				No.	%	No.	%	<1	1-3	3-5	>5
	China - Shangai	1992-1995	3284	3249	98.9	35	1.1	0.1	0.3	0.4	0.3	99.2	32.5
	Cuba	1994-1995	556	545	98.0	11	2.0	1.1	0.4	0.5	0.0	98.0	28.9
	India - Barshi	1993-2000	49	48	98.0	1	2.0	2.0	0.0	0.0	0.0	98.0	9.4
	India - Karunagappally	1991-1997	38	38	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	32.0
	India - Mumbai	1992-1994	1217	963	79.1	254	20.9	12.0	0.5	0.3	8.1	87.2	11.7
	Philippines - Manila	1994-1995	103	76	73.8	27	26.2	16.4	3.9	4.9	1.0	74.8	20.3
	Thailand - Chiang Mai	1993-1997	190	142	74.7	48	25.3	9.0	8.4	6.8	1.1	75.8	16.4
	Thailand - Khon Kaen	1993-1997	139	112	80.6	27	19.4	10.1	6.5	0.7	2.1	82.7	18.6
	Thailand - Lampang	1990-2000	249	247	99.2	2	0.8	0.0	0.0	0.4	0.4	99.6	24.0
	Thailand - Songkhla	1990-1999	203	133	65.5	70	34.5	10.3	9.9	7.9	6.4	71.9	20.3
	Turkey - Izmir	1995-1997	344	232	67.5	112	32.5	16.0	2.9	2.0	11.6	79.1	24.6
	Uganda - Kampala	1993-1997	50	40	80.0	10	20.0	18.0	2.0	0.0	0.0	80.0	9.4
	Zimbabwe - Harare	1993-1997	67	65	97.0	2	3.0	1.5	1.5	0.0	0.0	97.0	16.1

Other tables available:

- Table 1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b:	Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6:	Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9:	Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period